Combination of the preoperative albumin to globulin ratio and neutrophil to lymphocyte ratio as a novel prognostic factor in patients with triple negative breast cancer

References

• Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938–1948. doi:10.1056/NEJMra100138921067385
   PubMed Web of Science ®Google Scholar
• Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med. 2009;360(8):790–800. doi:10.1056/NEJMra080128919228622
   PubMed Web of Science ®Google Scholar
• McMillan DC. The systemic inflammation-based glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–540. doi:10.1016/j.ctrv.2012.08.00322995477
   PubMed Web of Science ®Google Scholar
• Paramanathan A, Saxena A, Morris DL. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surg Oncol. 2014;23(1):31–39. doi:10.1016/j.suronc.2013.12.00124378193
   PubMed Web of Science ®Google Scholar
• Dutta S, Crumley AB, Fullarton GM, Horgan PG, McMillan DC. Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer. World J Surg. 2011;35(8):1861–1866. doi:10.1007/s00268-011-1130-721538187
   PubMed Web of Science ®Google Scholar
• Wang J, Wang S, Song X, et al. The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma. Onco Targets Ther. 2016;9:7177–7185. doi:10.2147/OTT.S11330727920556
   PubMed Web of Science ®Google Scholar
• Rakha EA, Starczynski J, Lee AH, Ellis IO. The updated ASCO/CAP guideline recommendations for HER2 testing in the management of invasive breast cancer: a critical review of their implications for routine practice. Histopathology. 2014;64(5):609–615. doi:10.1111/his.1235724382093
   PubMed Web of Science ®Google Scholar
• Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784–2795. doi:10.1200/JCO.2009.25.652920404251
   PubMed Web of Science ®Google Scholar
• Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–35. 15405679
   PubMed Web of Science ®Google Scholar
• Gingras I, Azim HA Jr. , Ignatiadis M, Sotiriou C. Immunology and breast cancer: toward a new way of understanding breast cancer and developing novel therapeutic strategies. Clini adv hematol oncol H O. 2015;13(6):372–382.
   PubMedGoogle Scholar
• Bedognetti D, Hendrickx W, Marincola FM, Miller LD. Prognostic and predictive immune gene signatures in breast cancer. Curr Opin Oncol. 2015;27(6):433–444. doi:10.1097/CCO.000000000000023426418235
   PubMed Web of Science ®Google Scholar
• Jutagir DR, Blomberg BB, Carver CS, et al. Social well-being is associated with less pro-inflammatory and pro-metastatic leukocyte gene expression in women after surgery for breast cancer. Breast Cancer Res Treat. 2017;165(1):169–180. doi:10.1007/s10549-017-4316-328560656
   PubMed Web of Science ®Google Scholar
• Lv GY, An L, Sun XD, Hu YL, Sun DW. Pretreatment albumin to globulin ratio can serve as a prognostic marker in human cancers: a meta-analysis. Clin Chim Acta. 2018;476:81–91. doi:10.1016/j.cca.2017.11.01929170102
   PubMed Web of Science ®Google Scholar
• Jing CY, Fu YP, Shen HJ, et al. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection. Oncotarget. 2017;8(8):13293–13303. doi:10.18632/oncotarget.1453028076328
   PubMedGoogle Scholar
• Seaton K. Albumin concentration controls cancer. J Natl Med Assoc. 2001;93(12):490–493. 11800279
   PubMed Web of Science ®Google Scholar
• Kudarha RR, Sawant KK. Albumin based versatile multifunctional nanocarriers for cancer therapy: fabrication, surface modification, multimodal therapeutics and imaging approaches. Mater Sci Eng C Mate Biol Appl. 2017;81:607–626. doi:10.1016/j.msec.2017.08.004
   PubMed Web of Science ®Google Scholar
• Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69. doi:10.1186/1475-2891-9-6921176210
   PubMed Web of Science ®Google Scholar
• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–454. doi:10.1056/NEJM1999021134006079971870
   PubMed Web of Science ®Google Scholar
• Eliopoulos AG, Stack M, Dawson CW, et al. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors. Oncogene. 1997;14(24):2899–2916. doi:10.1038/sj.onc.12012589205097
   PubMed Web of Science ®Google Scholar
• Barber MD, Ross JA, Fearon KC. Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer. 1999;35(2):106–110. doi:10.1207/S15327914NC352_210693162
   PubMed Web of Science ®Google Scholar
• Shiroyama T, Suzuki H, Tamiya M, et al. Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer. Cancer Med. 2017;7(1):13-20.
   PubMed Web of Science ®Google Scholar
• Zhang F, Sun P, Wang ZQ, et al. Low preoperative albumin-globulin score predicts favorable survival in esophageal squamous cell carcinoma. Oncotarget. 2016;7(21):30550–30560. doi:10.18632/oncotarget.886827105522
   PubMedGoogle Scholar
• Lee Y, Kim SH, Han JY, Kim HT, Yun T, Lee JS. Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. J Cancer Res Clin Oncol. 2012;138(12):2009–2016. doi:10.1007/s00432-012-1281-422772951
   PubMed Web of Science ®Google Scholar
• De Larco JE, Wuertz BR, Furcht LT. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res. 2004;10(15):4895–4900. doi:10.1158/1078-0432.CCR-03-076015297389
   PubMed Web of Science ®Google Scholar
• Kemal Y, Yucel I, Ekiz K, et al. Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis. Asian Pac J Cancer Prev. 2014;15(6):2651–2654. 24761879
   PubMedGoogle Scholar
• Ohashi R, Takahashi K, Miura K, Ishiwata T, Sakuraba S, Fukuchi Y. Prognostic factors in patients with inoperable non-small cell lung cancer–an analysis of long-term survival patients. “Gan to Kagaku Ryoho Cancer Chemother. 2006;33(11):1595–1602.
   PubMedGoogle Scholar
• Peker KD, Ozkanli SS, Akyuz C, et al. Preoperative immunonutrition regulates tumor infiltrative lymphocytes and increases tumor angiogenesis in gastric cancer patients. Arch med sci. 2017;13(6):1365–1372. doi:10.5114/aoms.2016.6005429181067
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Usui S, Kikuchi S, et al. Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer. 2012;75(2):223–227. doi:10.1016/j.lungcan.2011.06.00921764477
   PubMed Web of Science ®Google Scholar
• Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91(3):181–184. doi:10.1002/jso.2032916118772
   PubMed Web of Science ®Google Scholar
• Wang L, Liang D, Xu X, et al. The prognostic value of neutrophil to lymphocyte and platelet to lymphocyte ratios for patients with lung cancer. Oncol Lett. 2017;14(6):6449–6456. doi:10.3892/ol.2017.704729163681
   PubMed Web of Science ®Google Scholar
• Demirci NS, Erdem GU. Prognostic role of the neutrophil-to-lymphocyte ratio (NLR) in patients with operable ampullary carcinoma. Bosnian J Basic Medl Sci. 2017. doi:10.17305/bjbms.2017.2530
   PubMed Web of Science ®Google Scholar
• Pistelli M, De Lisa M, Ballatore Z, et al. Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients. BMC Cancer. 2015;15:195. doi:10.1186/s12885-015-1584-325884918
   PubMed Web of Science ®Google Scholar
• Qiu X, Song Y, Cui Y, Liu Y. Increased neutrophil-lymphocyte ratio independently predicts poor survival in non-metastatic triple-negative breast cancer patients. Int Union Biochem Mol Biol Life. 2018;70(6):529–535. doi:10.1002/iub.1745
   Google Scholar
• Iwase T, Sangai T, Sakakibara M, et al. An increased neutrophil-to-lymphocyte ratio predicts poorer survival following recurrence for patients with breast cancer. Mol clin oncol. 2017;6(2):266–270. doi:10.3892/mco.2016.110128357108
   PubMed Web of Science ®Google Scholar
• Chae S, Kang KM, Kim HJ, et al. Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer. Curr oncol. 2018;25(2):e113–e119. doi:10.3747/co.25.388829719435
   PubMed Web of Science ®Google Scholar
• Bozkurt O, Karaca H, Berk V, et al. Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients. Offl J Balkan Union Oncol. 2015;20(6):1432–1439.
   PubMed Web of Science ®Google Scholar
• Jia W, Wu J, Jia H, et al. The peripheral blood neutrophil-to-lymphocyte ratio is superior to the lymphocyte-to-monocyte ratio for predicting the long-term survival of triple-negative breast cancer patients. PLoS One. 2015;10(11):e0143061. doi:10.1371/journal.pone.014306126580962
   PubMed Web of Science ®Google Scholar